Researchers have designed compounds called quinine dimers that work against sensitive and resistant strains of Plasmodium falciparum, the parasite causing severe malaria. These compounds bind to and block resistance-conferring proteins, resensitizing parasites to chloroquine and killing them.
A new study compares the relative rate of molecular evolution between humans and chimps with that of their lice. The researchers found that the lice are winning the molecular evolutionary race, with almost 15 times more changes in gene sequence.
African sleeping sickness is caused by single-celled parasites that mate and swap genes through a process known as sexual reproduction. This study reveals sex to be a regular part of the trypanosome life cycle, enabling new combinations of genes that could lead to disease-causing strains.
Scientists have identified a way to stop malaria parasites from multiplying by targeting the NMT enzyme, which is essential for various processes in the parasite. The discovery raises hopes for new treatments and could be effective against multiple species of malaria parasites.
A team of researchers has discovered a way to identify malaria-causing Plasmodium falciparum parasites that are resistant to artemisinin, the key drug for treating this disease. The study found that parasites with a mutant version of the K13-propeller gene were more likely to survive exposure to artemisinin.
Scientists at the University of Edinburgh made a groundbreaking discovery that could help combat the spread of sleeping sickness. By understanding how parasites communicate with each other, researchers may be able to develop new drugs to disrupt these messages and limit the disease's transmission.
Researchers found that alien harlequin ladybirds are less likely to be parasitized by common wasps and flies than native UK species. The study supports the Enemy Release Hypothesis, suggesting that native predators and parasites may struggle to attack invasive species.
Researchers have identified phosphatidylinositol 4-kinase (PI4K) as a potential malaria drug target, essential throughout the Plasmodium life cycle. Imidazopyrazines inhibit PI4K activity, blocking parasite development in both liver and bloodstream stages.
A team of scientists has identified the critical gene responsible for drug resistance in schistosome parasites. The finding could lead to improved therapies by redesigning the existing oxamniquine drug to target both major species, potentially saving millions of lives annually.
Researchers found that house sparrows' immune cells become more attuned to finding dangerous parasites at the edge of their range in Kenya. This adaptation may help the birds thrive in new areas with novel pathogens. The study aims to understand what gives invasive species an edge, informing efforts to manage and eradicate them.
A recent study published in PLOS ONE has provided the first explanation for type of antimalarial drug resistance. The research found a link between autophagy and resistance to malaria parasites, with implications for developing new antimalarial drug therapy.
Scientists have developed a 3D filming technique that helps researchers understand how malaria parasites mate and spread the disease. The unique motion of malaria sperm, moving in an irregular corkscrew motion, has revealed new insights into prevention and control methods.
Researchers found that certain mice develop IRG proteins, a resistance mechanism that prevents the parasites from killing them. This balance between parasite virulence and host resistance allows the infected mice to survive long enough for the parasites to complete their cycle.
Researchers discovered four genera of haemosporidian parasites in West African bats, closely related to the malaria pathogen Plasmodium. The study highlights the complex relationship between bats and pathogens, with potential implications for understanding human malaria evolution and developing new vaccines.
Researchers have identified Human Neutrophil Peptide-1 (HNP-1) as a potential treatment for leishmaniasis, a vector-borne disease affecting young individuals worldwide. HNP-1 has been shown to directly kill Leishmania parasites and increase the lifespan of neutrophils, reducing their susceptibility to infection.
Scientists find that malaria and toxoplasmosis parasites can survive without AMA1 protein, but still attach to host cells. This discovery challenges current therapeutic strategies and suggests alternative approaches for improving treatments.
Researchers found that patients who relapse after leishmaniasis treatment are infected with more infectious parasite strains, which cause a greater parasite load and make treatment challenging.
Researchers uncover a wide variety of malaria parasites in West African bats, including those closely related to rodent-infecting pathogens. The study reveals two bat-infecting parasites that made evolutionary jumps from rodents into bats and then likely back again.
A study published in Vaccine suggests that genetically engineered malaria parasites can be used as a vaccine to protect against infection. The attenuated parasites, which are stunted through precise gene deletions, induce robust immune responses that provide long-lasting protection.
A new simple and rapid test can clearly identify artemisinin-resistant malaria parasites in people with the disease. The test was developed using ring-stage survival assays (RSAs) and shows promise for use in field-based settings to monitor artemisinin resistance.
Researchers have developed two rapid tests to monitor resistance spread and screen new drugs for malaria. The simple tests can predict whether a patient has slow-clearing, drug-resistant parasites in just 72 hours.
Researchers found that permanent parasites that are normally a social burden protect their hosts against greater evils. The guest ants rise to defend their hosts against mobile raiders, greatly decreasing the probability of a raid. This co-evolutionary process maintains lesser evils when it helps prevent greater harm.
Tiny parasites, known as Mikrocytos mackini, have been found to infect Pacific oysters, causing unsightly green lesions and death. The discovery sheds light on the parasites' reduced metabolism and unique relationship with their host.
A benign crystal protein produced by bacteria could be a safe and inexpensive treatment for parasitic worms in humans. The protein, Cry5B, achieved a 93% elimination of hookworm parasites from infected hamsters.
A study found that over three-quarters of imported bumblebee colonies tested carried parasites, posing a risk to native bees and honeybees. The researchers argue that producers must improve disease screening and regulatory authorities must strengthen measures to prevent the importation of parasite-carrying colonies.
Increased precipitation and changes in forest structure in Argentina's forests are leading to higher rates of parasitic fly infection in young birds. This study found that slight changes in precipitation and vegetation structure, coupled with crowding of nests, result in large increases in the number of parasites per chick.
Researchers develop equations to estimate parasite and host metabolic rates, providing a new way to understand the energetics of parasites. The model reveals that there is a limit to how many worms can be accommodated in a host, with energy being the key limiting factor.
Researchers have developed a malaria vaccine using blood-stage parasites that are chemically attenuated, inducing immunity to multiple species. The study demonstrates protective immunity in mice for over 100 days, suggesting a promising approach to target human malaria species.
A recent study by UCSB researchers found that parasites add layers of complexity and density to food webs. Their complex life cycles and interactions with hosts also make them a crucial part of the food web ecosystem.
A Kansas State University researcher has received a prestigious fellowship to study mosquitoes and their role in spreading malaria. The goal is to understand how the mosquito's immune system responds to parasites, which could lead to new methods to limit parasite development and potentially find a cure for malaria.
A new paper analyzed seven coastal estuary and marine food webs, including parasites, to understand their impact on network structure. The team found that most changes resulted from increased diversity and complexity, rather than unique parasite characteristics.
Researchers found that including parasites in food web models changes the distribution of feeding links per species, average shortest feeding chain between pairs of species, and proportion of omnivores or cannibals. Most changes occur due to increased diversity and complexity, rather than parasite-specific effects.
Researchers discovered how malaria parasites stick to blood vessels by binding to endothelial protein C receptor (EPCR). This finding may lead to new means of combating malaria, including vaccines and drugs. The discovery sheds light on the mechanisms behind severe malaria symptoms.
Adult wild chimpanzees exhibit a strong association between age and malaria parasite detection rates, with significantly lower positivity in adults. This suggests that individuals reaching adulthood mount an effective protective immunity against malaria parasites, consistent with human observations.
Researchers found that mosquitoes may be responding to an immune challenge rather than manipulating their behavior to transmit malaria parasites. Mosquitoes will wait to feed until the parasites mature and migrate to the salivary glands, but this response is also seen in non-infected mosquitoes.
A new LAMP test kit can detect even the lowest levels of malaria parasites in under an hour, improving diagnosis for imported UK cases and field use in Uganda. The simple test requires minimal equipment and training, making it accessible to non-specialist health workers.
Researchers discovered malaria parasites can send signals to each other in infected red blood cells, triggering transformation into sexually mature forms that can be transmitted to mosquitoes. This social behavior could provide a target for developing new antimalarial drugs or vaccines.
A study published in PLOS ONE found that female mosquitoes infected with malaria parasites are significantly more attracted to human odour than uninfected mosquitoes. The team aims to identify the chemical compounds in human odour that attract infected mosquitoes, which could help develop improved mosquito traps.
Researchers have successfully infected mosquitoes with the Wolbachia bacterium, rendering them immune to malaria parasites. The scientists maintained a stable infection in Anopheles stephensi mosquitoes for 34 generations, and all infected female mosquitoes became infected within eight generations when mated with uninfected males.
Researchers found that animals use various methods to self-medicate, including learning and innate behaviors. This practice has significant implications for the ecology and evolution of animal hosts and their parasites.
Researchers identified a new class of anti-malarial compounds, 4-(1 H )-quinolone-3-diarylethers, derived from endochin, which effectively treats malaria in birds. The compounds demonstrated strong activity against Plasmodium falciparum and Plasmodium vivax, the parasites responsible for most human cases of malaria.
A novel screening method using genetically engineered baker's yeast identifies chemical compounds that target disease-causing parasites without harming human hosts. The approach has shown promise in identifying potential anti-parasitic compounds with high sensitivity, reducing costs, and increasing reproducibility.
Researchers developed a model that calculates how temperature changes affect parasite metabolism and life cycle, helping to predict disease ranges. The Princeton metabolic model can identify prospects for nearly any disease-causing parasite, even with limited knowledge of the organism.
Researchers have found that immature malaria parasites are significantly less sensitive to artemisinin-based drugs than mature ones. This discovery may lead to more effective treatments for malaria and a better understanding of how the parasite develops resistance to drugs.
Researchers discovered fossilized tapeworm eggs in 270-million-year-old shark feces, indicating that intestinal parasites in vertebrates are much older than previously known. The finding provides a new timeline for the evolution of present-day parasitic tapeworms.
A large-scale study reveals that parasites and inadequate prenatal care contribute significantly to epilepsy prevalence in sub-Saharan Africa. The research found that adults with parasitic infections were 1.5-3 times more likely to have epilepsy than those without exposure.
Climate change in Madagascar could fuel the spread of lemur parasites, carrying diseases like plague and typhus. The team created probability maps of likely parasite distributions today and estimated future expansions by up to 60%.
Researchers identified a host signaling pathway used by malaria parasites to escape host cells, allowing for potential new strategies to combat the disease. A compound called sotrastaurin, already tested in humans and deemed safe, showed promise as an oral antimalarial.
Scientists have developed a new method for studying parasite numbers in individual seabirds in the wild, using endoscopy. The technique found that all birds had parasites ranging from low burdens of several worms to high burdens of over 40 worms, with higher burdens in males and late breeders.
Researchers at UGA have found that an algal structure allows parasites like malaria and toxoplasmosis to replicate and spread inside hosts. Altering this fiber may lead to new anti-parasitic treatments.
Researchers found that an ancient algal structure is used by deadly parasites like malaria and toxoplasmosis to replicate inside hosts. Altering this fiber-like structure can prevent parasite replication, potentially leading to new treatments.
A group of parasites hijack their victims' nervous systems, reducing them to helpless zombies. These manipulators can have a significant impact on ecology, physiology, and evolution, orchestrating the behaviour of vertebrates and invertebrates.
Recent research revealed mosquitoes possess surprisingly effective immune systems, destroying pathogens by utilizing the circulatory system's unique characteristics. A Vanderbilt study discovered a new mechanism for eliminating pathogens, increasing effectiveness in disease control strategies.
A recent study found that male malaria parasites can adapt faster to their surroundings, making them harder to treat. Targeting the slower-reproducing female parasites could lead to more effective long-term treatments and prevent parasite breeding.
Researchers at Radboud University Medical Center have developed an injectable formulation of malaria parasites that can achieve controlled infection in human volunteers. The breakthrough could make it easier to evaluate new drugs and vaccines, as well as potentially become a vaccine itself.
Researchers have discovered a new potential treatment for malaria that rapidly kills the blood-borne Plasmodium parasites. The molecules identified can target all stages of the parasite's life cycle, offering hope for an effective cure within ten years.
Scientists have observed that chloroquine is once again effective in combating malaria parasites, particularly in Senegal and other African countries. This development could lead to more affordable treatment options for millions of people in Africa, with the current treatment costing twice as much as chloroquine.
Researchers develop a human liver-chimeric mouse model to study malaria parasites and understand human host/parasite interactions. Additionally, studies reveal the link between serum ferritin levels and insulin sensitivity, as well as the role of granulocyte-colony stimulating factor in protecting against influenza infection.
Researchers found Hematodinium sp. and its sister species are a major problem for crab fisheries, causing 'bitter crab' disease. The parasites have bacteria-like endosymbionts that increase their chances of survival outside the shrimp, leading to significant damage to infected crustaceans.
Researchers developed a targeted antisense approach to treat toxoplasmosis, reducing viable parasites by over 90% in mice. The therapy combines short nucleic acid strands with peptides to disrupt genetic signals, with potential applications in non-parasitic diseases.